AryaA, BatraHV, SahaiP, MukherjeeR. Production and characterization of new murine monoclonal antibodies reactive to Mycobacterium tuberculosis. Hybridoma, 1994; 13:21–30.
2.
ChanED, HeifetsL, IsemanMD. Immunologic diagnosis of tuberculosis: a review. Tuber Lung Dis, 2000; 80:131–140.
3.
ChangZ, PrimmTP, JakanaJ, LeeIH, SeryshevaI, ChiuW, GilbertHF, QuiochoFA. Mycobacterium tuberculosis 16-kDa antigen (Hsp16.3) functions as an oligomeric structure in vitro to suppress thermal aggregation. J Biol Chem, 1996; 271:7218–7223.
4.
DanielTM, DebanneSM. The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay. Am Rev Respir Dis, 1987; 135:1137–1151.
5.
El-MasryS, El-KadyI, ZaghloulMH, Al-BadraweyMK. Rapid and simple detection of a mycobacterium circulating antigen in serum of pulmonary tuberculosis patients by using a monoclonal antibody and Fast-Dot-ELISA. Clin Biochem, 2008; 41:145–151.
6.
HorwitzMA, LeeBW, DillonBJ, HarthG. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA, 1995; 92:1530–1534.
7.
LuoY, WangB, HuL, YuH, DaZ, JiangW, SongN, QieY, WangH, TangZ, XianQ, ZhangY, ZhuB. Fusion protein Ag85B-MPT64(190–198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice. Vaccine, 2009; 27:6179–6185.
8.
Organization World Health. Global tuberculosis control. World Health Organization, 2008; 1–14.
9.
ParkerSK, BarkleyRM, RinoJG, VasilML. Mycobacterium tuberculosis Rv3802c encodes a phospholipase/thioesterase and is inhibited by the antimycobacterial agent tetrahydrolipstatin. PLoS One, 2009; 4:e4281.
10.
RavnP, DemissieA, EgualeT, WondwossonH, LeinD, AmoudyHA, MustafaAS, JensenAK, HolmA, RosenkrandsI, OftungF, OloboJ, von ReynF, AndersenP. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis, 1999; 179:637–645.
11.
ShiC, ZhangH, ZhangT, WangX, BaiB, ZhaoY, ZhangC, XuZ. New alternative vaccine component against mycobacterium tuberculosis––heat shock protein 16.3 or its T-cell epitope. Scand J Immunol, 2009; 70:465–474.
12.
StarckJ, KalleniusG, MarklundBI, AnderssonDI, AkerlundT. Comparative proteome analysis of Mycobacterium tuberculosis grown under aerobic and anaerobic conditions. Microbiology, 2004; 150:3821–3829.
13.
UlrichsT, MunkME, MollenkopfH, Behr-PerstS, ColangeliR, GennaroML, KaufmannSH. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur J Immunol, 1998; 28:3949–3958.
14.
ValdezMM, ClarkJI, WuGJ, MuchowskiPJ. Functional similarities between the small heat shock proteins Mycobacterium tuberculosis HSP 16.3 and human alphaB-crystallin. Eur J Biochem, 2002; 269:1806–1813.
15.
VerbonA, HartskeerlRA, SchuitemaA, KolkAH, YoungDB, LathigraR. The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins. J Bacteriol, 1992; 174:1352–1359.
16.
ZhangH, ShiCH, XueY, BaiYL, WangLM, XuZK. Immune response and protective efficacy induced by fusion protein ESAT6-CFP10 of M. tuberculosis in mice. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2006; 22:443–446.